Latin America, with its large urban population and wealth of well-qualified medical professionals, is becoming a preferred destination for clinical trials. From 2005 to 2008, regional participation in clinical trials increased by an eye-popping 30.7%. In comparison, study participation decreased in both the U.S. and Europe. What is making Latin America such a favored location for drug studies?